Magnesium Orotate

Niche cardiovascular application with limited but positive data for congestive heart failure. Expensive and low elemental magnesium content limits general use.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

A few clinical studies suggest magnesium orotate improves survival and symptoms in congestive heart failure. Orotic acid may support cardiac energy metabolism via pyrimidine synthesis. However, trials are small and old. The form provides only ~6.5% elemental magnesium by weight.

• May support cardiac function in heart failure patients
• Orotic acid supports cellular energy metabolism
• Well-absorbed magnesium form

Cardiovascular studies used 3000-6000 mg magnesium orotate daily (providing ~200-400 mg elemental Mg). General supplementation is uncommon due to cost.

• GI discomfort
• Diarrhea at higher doses
• Expensive for adequate dosing

Very low elemental magnesium content. Not a practical choice for correcting general magnesium deficiency. Expensive per mg of elemental magnesium.

Cardiovascular studies are few and of moderate quality. Whether orotic acid adds meaningful benefit over other magnesium forms is unclear. Historical interest exceeds current evidence base.

• Longevity30
• Energy25